Selective T cell-depleted haploidentical hematopoietic stem cell transplantation for relapsed/refractory neuroblastoma-Reference-Cited by-同舟云学术

Selective T cell-depleted haploidentical hematopoietic stem cell transplantation for relapsed/refractory neuroblastoma

Published:2018-06-19 Issue:6 Volume:22 Page:e13240
ISSN:1397-3142
Container-title:Pediatric Transplantation
language:en
Short-container-title:Pediatr Transplant

Author:

Liu Anthony P. Y.¹^ORCID,Lee Pamela P. W.¹,Kwok Janette S. Y.²,Leung Rock Y. Y.³,Chiang Alan K. S.¹,Ha Shau-Yin¹,Cheuk Daniel K. L.¹,Chan Godfrey C. F.¹

Affiliation:

1. Department of Paediatrics and Adolescent Medicine; The University of Hong Kong; Queen Mary Hospital; Hong Kong SAR China

2. Division of Transplantation and Immunogenetics; Department of Pathology; Queen Mary Hospital; Hong Kong SAR China

3. Department of Pathology; Queen Mary Hospital; Hong Kong SAR China

Funder

Children's Cancer Foundation

Publisher

Wiley

Subject

Transplantation,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/petr.13240/fullpdf

Reference31 articles.

1. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma;Basta;Br J Cancer,2016

2. 28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures;Ladenstein;Bone Marrow Transplant,2008

3. Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma;Yu;N Engl J Med,2010

4. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid;Matthay;N Engl J Med,1999

5. Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015;Sureda;Bone Marrow Transplant,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II Study of Allogeneic Hematopoietic Stem Cell Transplantation for Children with High-Risk Neuroblastoma Using a Reduced-Intensity Conditioning Regimen: Results from the AIEOP Trial;Transplantation and Cellular Therapy;2024-05

2. Outcome of children with relapsed high-risk neuroblastoma in Japan and analysis of the role of allogeneic hematopoietic stem cell transplantation;Japanese Journal of Clinical Oncology;2022-02-05

3. Combining Immunocytokine and Ex Vivo Activated NK Cells as a Platform for Enhancing Graft-Versus-Tumor Effects Against GD2+ Murine Neuroblastoma;Frontiers in Immunology;2021-08-19

4. The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation;Frontiers in Immunology;2019-12-03